img

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Gastrointestinal Stromal Tumor (GIST) Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gastrointestinal Stromal Tumor (GIST) Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinic and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gastrointestinal Stromal Tumor (GIST) Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Gastrointestinal Stromal Tumor (GIST) Drug key manufacturers include Ariad Pharmaceuticals, Inc., Arog Pharmaceuticals, Inc., Array BioPharma Inc., Astex Pharmaceuticals, Inc., Blueprint Medicines Corporation, Boston Biomedical, Inc., Calithera Biosciences, Inc., Chipscreen Biosciences Ltd and Deciphera Pharmaceuticals, LLC, etc. Ariad Pharmaceuticals, Inc., Arog Pharmaceuticals, Inc., Array BioPharma Inc. are top 3 players and held % sales share in total in 2022.
Gastrointestinal Stromal Tumor (GIST) Drug can be divided into Amcasertib, Anagrelide hydrochloride CR, APG-1351 and Binimetinib, etc. Amcasertib is the mainstream product in the market, accounting for % sales share globally in 2022.
Gastrointestinal Stromal Tumor (GIST) Drug is widely used in various fields, such as Clinic, Hospital and Others,, etc. Clinic provides greatest supports to the Gastrointestinal Stromal Tumor (GIST) Drug industry development. In 2022, global % sales of Gastrointestinal Stromal Tumor (GIST) Drug went into Clinic filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gastrointestinal Stromal Tumor (GIST) Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
Segment by Type
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others

Segment by Application


Clinic
Hospital
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gastrointestinal Stromal Tumor (GIST) Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gastrointestinal Stromal Tumor (GIST) Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gastrointestinal Stromal Tumor (GIST) Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Gastrointestinal Stromal Tumor (GIST) Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gastrointestinal Stromal Tumor (GIST) Drug introduction, etc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Gastrointestinal Stromal Tumor (GIST) Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Gastrointestinal Stromal Tumor (GIST) Drug Market Overview
1.1 Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
1.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Segment by Type
1.2.1 Amcasertib
1.2.2 Anagrelide hydrochloride CR
1.2.3 APG-1351
1.2.4 Binimetinib
1.2.5 Others
1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2018-2024)
2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Competition by Company
2.1 Global Top Players by Gastrointestinal Stromal Tumor (GIST) Drug Sales (2018-2024)
2.2 Global Top Players by Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2018-2024)
2.3 Global Top Players by Gastrointestinal Stromal Tumor (GIST) Drug Price (2018-2024)
2.4 Global Top Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
2.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor (GIST) Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Gastrointestinal Stromal Tumor (GIST) Drug Market
2.8 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gastrointestinal Stromal Tumor (GIST) Drug Status and Outlook by Region
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Region
3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region (2018-2024)
3.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Region
3.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region (2024-2034)
3.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Gastrointestinal Stromal Tumor (GIST) Drug by Application
4.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Segment by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Others
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2018-2024)
5 North America Gastrointestinal Stromal Tumor (GIST) Drug by Country
5.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Country
5.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2018-2024)
5.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Country
5.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2024-2034)
6 Europe Gastrointestinal Stromal Tumor (GIST) Drug by Country
6.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Country
6.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2018-2024)
6.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Country
6.2.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug by Region
7.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Region
7.1.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region (2024-2034)
8 Latin America Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Country
8.1.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2018-2024)
8.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Country
8.2.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug by Country
9.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Country
9.1.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Ariad Pharmaceuticals, Inc.
10.1.1 Ariad Pharmaceuticals, Inc. Company Information
10.1.2 Ariad Pharmaceuticals, Inc. Introduction and Business Overview
10.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.1.5 Ariad Pharmaceuticals, Inc. Recent Development
10.2 Arog Pharmaceuticals, Inc.
10.2.1 Arog Pharmaceuticals, Inc. Company Information
10.2.2 Arog Pharmaceuticals, Inc. Introduction and Business Overview
10.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.2.5 Arog Pharmaceuticals, Inc. Recent Development
10.3 Array BioPharma Inc.
10.3.1 Array BioPharma Inc. Company Information
10.3.2 Array BioPharma Inc. Introduction and Business Overview
10.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.3.5 Array BioPharma Inc. Recent Development
10.4 Astex Pharmaceuticals, Inc.
10.4.1 Astex Pharmaceuticals, Inc. Company Information
10.4.2 Astex Pharmaceuticals, Inc. Introduction and Business Overview
10.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.4.5 Astex Pharmaceuticals, Inc. Recent Development
10.5 Blueprint Medicines Corporation
10.5.1 Blueprint Medicines Corporation Company Information
10.5.2 Blueprint Medicines Corporation Introduction and Business Overview
10.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.5.5 Blueprint Medicines Corporation Recent Development
10.6 Boston Biomedical, Inc.
10.6.1 Boston Biomedical, Inc. Company Information
10.6.2 Boston Biomedical, Inc. Introduction and Business Overview
10.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.6.5 Boston Biomedical, Inc. Recent Development
10.7 Calithera Biosciences, Inc.
10.7.1 Calithera Biosciences, Inc. Company Information
10.7.2 Calithera Biosciences, Inc. Introduction and Business Overview
10.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.7.5 Calithera Biosciences, Inc. Recent Development
10.8 Chipscreen Biosciences Ltd
10.8.1 Chipscreen Biosciences Ltd Company Information
10.8.2 Chipscreen Biosciences Ltd Introduction and Business Overview
10.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.8.5 Chipscreen Biosciences Ltd Recent Development
10.9 Deciphera Pharmaceuticals, LLC
10.9.1 Deciphera Pharmaceuticals, LLC Company Information
10.9.2 Deciphera Pharmaceuticals, LLC Introduction and Business Overview
10.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.9.5 Deciphera Pharmaceuticals, LLC Recent Development
10.10 F. Hoffmann-La Roche Ltd.
10.10.1 F. Hoffmann-La Roche Ltd. Company Information
10.10.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.10.5 F. Hoffmann-La Roche Ltd. Recent Development
10.11 Horizon Pharma Plc
10.11.1 Horizon Pharma Plc Company Information
10.11.2 Horizon Pharma Plc Introduction and Business Overview
10.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.11.5 Horizon Pharma Plc Recent Development
10.12 Immunicum AB
10.12.1 Immunicum AB Company Information
10.12.2 Immunicum AB Introduction and Business Overview
10.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.12.5 Immunicum AB Recent Development
10.13 Jiangsu Hengrui Medicine Co., Ltd.
10.13.1 Jiangsu Hengrui Medicine Co., Ltd. Company Information
10.13.2 Jiangsu Hengrui Medicine Co., Ltd. Introduction and Business Overview
10.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Development
10.14 Kolltan Pharmaceuticals, Inc.
10.14.1 Kolltan Pharmaceuticals, Inc. Company Information
10.14.2 Kolltan Pharmaceuticals, Inc. Introduction and Business Overview
10.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.14.5 Kolltan Pharmaceuticals, Inc. Recent Development
10.15 Natco Pharma Limited
10.15.1 Natco Pharma Limited Company Information
10.15.2 Natco Pharma Limited Introduction and Business Overview
10.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.15.5 Natco Pharma Limited Recent Development
10.16 Nerviano Medical Sciences S.r.l.
10.16.1 Nerviano Medical Sciences S.r.l. Company Information
10.16.2 Nerviano Medical Sciences S.r.l. Introduction and Business Overview
10.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.16.5 Nerviano Medical Sciences S.r.l. Recent Development
10.17 Novartis AG
10.17.1 Novartis AG Company Information
10.17.2 Novartis AG Introduction and Business Overview
10.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.17.5 Novartis AG Recent Development
10.18 Omeros Corporation
10.18.1 Omeros Corporation Company Information
10.18.2 Omeros Corporation Introduction and Business Overview
10.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
10.18.5 Omeros Corporation Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
11.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Dynamics
11.4.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends
11.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
11.4.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
11.4.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
12.3 Gastrointestinal Stromal Tumor (GIST) Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Amcasertib
Table 2. Major Company of Anagrelide hydrochloride CR
Table 3. Major Company of APG-1351
Table 4. Major Company of Binimetinib
Table 5. Major Company of Others
Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2024) & (US& Million)
Table 10. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share in Value by Type (2018-2024)
Table 11. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type (2024-2034)
Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Company (2018-2024)
Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Company (2018-2024)
Table 31. Global Market Gastrointestinal Stromal Tumor (GIST) Drug Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor (GIST) Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Gastrointestinal Stromal Tumor (GIST) Drug Market
Table 36. Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Region (2018-2024)
Table 43. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Region (2024-2034)
Table 48. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application (2018-2024)
Table 54. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application (2024-2034)
Table 59. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) (K Pcs)
Table 61. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Country (2018-2024)
Table 74. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Country (2024-2034)
Table 110. Ariad Pharmaceuticals, Inc. Company Information
Table 111. Ariad Pharmaceuticals, Inc. Introduction and Business Overview
Table 112. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 114. Ariad Pharmaceuticals, Inc. Recent Development
Table 115. Arog Pharmaceuticals, Inc. Company Information
Table 116. Arog Pharmaceuticals, Inc. Introduction and Business Overview
Table 117. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 119. Arog Pharmaceuticals, Inc. Recent Development
Table 120. Array BioPharma Inc. Company Information
Table 121. Array BioPharma Inc. Introduction and Business Overview
Table 122. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 124. Array BioPharma Inc. Recent Development
Table 125. Astex Pharmaceuticals, Inc. Company Information
Table 126. Astex Pharmaceuticals, Inc. Introduction and Business Overview
Table 127. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 129. Astex Pharmaceuticals, Inc. Recent Development
Table 130. Blueprint Medicines Corporation Company Information
Table 131. Blueprint Medicines Corporation Introduction and Business Overview
Table 132. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 134. Blueprint Medicines Corporation Recent Development
Table 135. Boston Biomedical, Inc. Company Information
Table 136. Boston Biomedical, Inc. Introduction and Business Overview
Table 137. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 139. Boston Biomedical, Inc. Recent Development
Table 140. Calithera Biosciences, Inc. Company Information
Table 141. Calithera Biosciences, Inc. Introduction and Business Overview
Table 142. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 144. Calithera Biosciences, Inc. Recent Development
Table 145. Chipscreen Biosciences Ltd Company Information
Table 146. Chipscreen Biosciences Ltd Introduction and Business Overview
Table 147. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 149. Chipscreen Biosciences Ltd Recent Development
Table 150. Deciphera Pharmaceuticals, LLC Company Information
Table 151. Deciphera Pharmaceuticals, LLC Introduction and Business Overview
Table 152. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 154. Deciphera Pharmaceuticals, LLC Recent Development
Table 155. F. Hoffmann-La Roche Ltd. Company Information
Table 156. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 157. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 159. F. Hoffmann-La Roche Ltd. Recent Development
Table 160. Horizon Pharma Plc Company Information
Table 161. Horizon Pharma Plc Introduction and Business Overview
Table 162. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 163. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 164. Horizon Pharma Plc Recent Development
Table 165. Immunicum AB Company Information
Table 166. Immunicum AB Introduction and Business Overview
Table 167. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 168. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 169. Immunicum AB Recent Development
Table 170. Jiangsu Hengrui Medicine Co., Ltd. Company Information
Table 171. Jiangsu Hengrui Medicine Co., Ltd. Introduction and Business Overview
Table 172. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 173. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 174. Jiangsu Hengrui Medicine Co., Ltd. Recent Development
Table 175. Kolltan Pharmaceuticals, Inc. Company Information
Table 176. Kolltan Pharmaceuticals, Inc. Introduction and Business Overview
Table 177. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 178. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 179. Kolltan Pharmaceuticals, Inc. Recent Development
Table 180. Natco Pharma Limited Company Information
Table 181. Natco Pharma Limited Introduction and Business Overview
Table 182. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 183. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 184. Natco Pharma Limited Recent Development
Table 185. Nerviano Medical Sciences S.r.l. Company Information
Table 186. Nerviano Medical Sciences S.r.l. Introduction and Business Overview
Table 187. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 188. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 189. Nerviano Medical Sciences S.r.l. Recent Development
Table 190. Novartis AG Company Information
Table 191. Novartis AG Introduction and Business Overview
Table 192. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 193. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 194. Novartis AG Recent Development
Table 195. Omeros Corporation Company Information
Table 196. Omeros Corporation Introduction and Business Overview
Table 197. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 198. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 199. Omeros Corporation Recent Development
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Gastrointestinal Stromal Tumor (GIST) Drug Market Trends
Table 203. Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
Table 204. Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
Table 205. Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
Table 206. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table 207. Gastrointestinal Stromal Tumor (GIST) Drug Downstream Customers
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Product Picture
Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Amcasertib
Figure 6. Global Amcasertib Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Anagrelide hydrochloride CR
Figure 8. Global Anagrelide hydrochloride CR Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of APG-1351
Figure 10. Global APG-1351 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Binimetinib
Figure 12. Global Binimetinib Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2022 & 2034
Figure 17. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Gastrointestinal Stromal Tumor (GIST) Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Gastrointestinal Stromal Tumor (GIST) Drug Revenue in 2022
Figure 29. Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2022 & 2034
Figure 38. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Cost Structure
Figure 49. Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries